Collaborative alliances with leading companies create synergies and opportunities for expanding our efforts in drug discovery. Current research alliances involve advanced genomics, screening libraries, expertise in combinatorial chemistry, and proprietary tools and technologies for lead identification and target validation.
We participate in alliances with companies including the following:

